| dc.contributor.author |
MUKHERJEE S. |
|
| dc.contributor.author |
PANDA D. |
|
| dc.date.accessioned |
2023-03-17T04:35:23Z |
|
| dc.date.available |
2023-03-17T04:35:23Z |
|
| dc.date.issued |
2021 |
|
| dc.identifier.citation |
ACS Chemical Neuroscience,12(23)4393-4405 |
en_US |
| dc.identifier.issn |
19487193 |
|
| dc.identifier.uri |
https://dx.doi.org/10.1021/acschemneuro.1c00377 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/100/37171 |
|
| dc.description.abstract |
The dysregulation of metal homeostasis is reported to enhance the aggregation of tau, a key neuronal microtubule-associated protein. Herein, we found that ferric (fe3+) ions enhanced tau aggregation. Fe3+ and al3+ induced tau aggregation while several trivalent metal ions such as cr3+, la3+, and v3+ had no discernable effect on tau aggregation. Fe3+ reduced the critical concentration of tau required for the liquid-liquid phase separation (llps); however, cr3+, la3+, and v3+ did not affect tau droplet formation. Dynamic light scattering, atomic force microscopic, and transmission electron microscopic analysis suggested that fe3+ significantly increased the formation of tau oligomers and fibrils. In contrast, fe2+ neither enhanced tau droplet formation nor increased the heparin-induced aggregation of tau. Using a tryptophan mutant (y310w-tau) of tau, fe3+ was found to bind to tau with four times higher affinity than fe2+. Acrylamide quenching of the tryptophan fluorescence of y310w-tau, 1-anilino-8-naphthalene sulfonate (ans) fluorescence experiment, and far-uv circular dichroism analysis indicated that fe3+ decreased the solvent exposure of the tryptophan residue, perturbed the hydrophobic surface arrangement, and disrupted the secondary structure of tau, respectively. The increase in the β-sheet content and a subsequent decrease in the disordered content of tau due to the binding of fe3+ may favor tau aggregation. Fe3+ may enhance and stabilize the non-covalent interactions between disordered domains of tau molecules leading to tau aggregation. The data highlighted the relationship between the dysregulation of ferric ions and neurodegenerative disorders. © 2021 american chemical society. |
en_US |
| dc.language.iso |
English |
en_US |
| dc.publisher |
American Chemical Society |
en_US |
| dc.subject |
ALZHEIMER'S DISEASE |
en_US |
| dc.subject |
IRON |
en_US |
| dc.subject |
LIQUID-LIQUID PHASE SEPARATION |
en_US |
| dc.subject |
TAU |
en_US |
| dc.subject |
TAU AGGREGATION |
en_US |
| dc.subject |
TRIVALENT METAL IONS |
en_US |
| dc.subject.other |
aluminum |
en_US |
| dc.subject.other |
ferric ion |
en_US |
| dc.subject.other |
ferrous ion |
en_US |
| dc.subject.other |
heparin |
en_US |
| dc.subject.other |
macrogol 8000 |
en_US |
| dc.subject.other |
tau protein |
en_US |
| dc.subject.other |
ion |
en_US |
| dc.subject.other |
metal |
en_US |
| dc.subject.other |
Article |
en_US |
| dc.subject.other |
atomic force microscopy |
en_US |
| dc.subject.other |
beta sheet |
en_US |
| dc.subject.other |
binding affinity |
en_US |
| dc.subject.other |
circular dichroism |
en_US |
| dc.subject.other |
concentration (parameter) |
en_US |
| dc.subject.other |
conformational transition |
en_US |
| dc.subject.other |
controlled study |
en_US |
| dc.subject.other |
dissociation constant |
en_US |
| dc.subject.other |
fluorescence analysis |
en_US |
| dc.subject.other |
fluorescence intensity |
en_US |
| dc.subject.other |
gene mutation |
en_US |
| dc.subject.other |
hydrophobicity |
en_US |
| dc.subject.other |
metal binding |
en_US |
| dc.subject.other |
molecular interaction |
en_US |
| dc.subject.other |
molecular size |
en_US |
| dc.subject.other |
molecular stability |
en_US |
| dc.subject.other |
oligomerization |
en_US |
| dc.subject.other |
particle size |
en_US |
| dc.subject.other |
phase separation |
en_US |
| dc.subject.other |
photon correlation spectroscopy |
en_US |
| dc.subject.other |
protein aggregation |
en_US |
| dc.subject.other |
protein binding |
en_US |
| dc.subject.other |
protein conformation |
en_US |
| dc.subject.other |
protein modification |
en_US |
| dc.subject.other |
protein secondary structure |
en_US |
| dc.subject.other |
structure activity relation |
en_US |
| dc.subject.other |
surface charge |
en_US |
| dc.subject.other |
tauopathy |
en_US |
| dc.subject.other |
transmission electron microscopy |
en_US |
| dc.subject.other |
human |
en_US |
| dc.subject.other |
tauopathy |
en_US |
| dc.subject.other |
Circular Dichroism |
en_US |
| dc.subject.other |
Humans |
en_US |
| dc.subject.other |
Ions |
en_US |
| dc.subject.other |
Metals |
en_US |
| dc.subject.other |
tau Proteins |
en_US |
| dc.subject.other |
Tauopathies |
en_US |
| dc.title |
Contrasting Effects of Ferric and Ferrous Ions on Oligomerization and Droplet Formation of Tau: Implications in Tauopathies and Neurodegeneration |
en_US |
| dc.type |
Article |
en_US |